SEMI-SUPERVISED ANALYSIS OF HUMAN BRAIN TUMOURS FROM PARTIALLY LABELED MRS INFORMATION, USING MANIFOLD LEARNING MODELS

2011 ◽  
Vol 21 (01) ◽  
pp. 17-29 ◽  
Author(s):  
RAÚL CRUZ-BARBOSA ◽  
ALFREDO VELLIDO

Medical diagnosis can often be understood as a classification problem. In oncology, this typically involves differentiating between tumour types and grades, or some type of discrete outcome prediction. From the viewpoint of computer-based medical decision support, this classification requires the availability of accurate diagnoses of past cases as training target examples. The availability of such labeled databases is scarce in most areas of oncology, and especially so in neuro-oncology. In such context, semi-supervised learning oriented towards classification can be a sensible data modeling choice. In this study, semi-supervised variants of Generative Topographic Mapping, a model of the manifold learning family, are applied to two neuro-oncology problems: the diagnostic discrimination between different brain tumour pathologies, and the prediction of outcomes for a specific type of aggressive brain tumours. Their performance compared favorably with those of the alternative Laplacian Eigenmaps and Semi-Supervised SVM for Manifold Learning models in most of the experiments.

2015 ◽  
Vol 42 (22) ◽  
pp. 8982-8988 ◽  
Author(s):  
Paulo J.G. Lisboa ◽  
José D. Martín-Guerrero ◽  
Alfredo Vellido

2020 ◽  
Author(s):  
Uswa Shahzad ◽  
Michael S Taccone ◽  
Sachin A Kumar ◽  
Hidehiro Okura ◽  
Stacey Krumholtz ◽  
...  

Abstract For decades, cell biologists and cancer researchers have taken advantage of non-murine species to increase our understanding of the molecular processes that drive normal cell and tissue development, and when perturbed, cause cancer. The advent of whole genome sequencing has revealed the high genetic homology of these organisms to humans. Seminal studies in non-murine organisms such as D. melanogaster, C. elegans, and D. rerio identified many of the signaling pathways involved in cancer. Studies in these organisms offer distinct advantages over mammalian cell or murine systems. Compared to murine models, these three species have shorter lifespans, are less resource intense, and are amenable to high-throughput drug and RNA interference screening to test a myriad of promising drugs against novel targets. In this review, we introduce species specific breeding strategies, highlight the advantages of modeling brain tumours in each non-mammalian species, and underscore the successes attributed to scientific investigation using these models. We conclude with an optimistic proposal that discoveries in the fields of cancer research, and in particular neuro-oncology, may be expedited using these powerful screening tools and strategies.


Sign in / Sign up

Export Citation Format

Share Document